us-news san-francisco 
pharmaphorum
JULY 13, 2022
AG Letitia James says the Israeli drugmaker “made significant and intentional misrepresentations” to her office and the court about its involvement with its US subsidiary in order to evade legal action and accountability. Last December, the US unit was found accountable for playing a part in fueling the opioid crisis in the state.
pharmaphorum
JANUARY 18, 2022
According to Rock Health’s annual digital health funding report, US-based digital health companies enabling life sciences research and development raised $5.8 This is the first time R&D has topped the chart since Rock Health began tracking US digital health funding in 2011, although it nabbed the number two slot in 2018 and 2020.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 12, 2022
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. Turalio, meanwhile, was approved by the FDA in 2019 in a very rare tumour type, and isn’t expected to generate large revenues.
pharmaphorum
JANUARY 13, 2023
Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres, hotel rooms, and rain-soaked Lyfts of San Francisco. After my customary cross-country redeye, I’ve officially traded the relentless rain of San Francisco for the gentle snowfall of my native Boston. Conclusion.
pharmaphorum
JANUARY 6, 2022
Morgan week has historically brought large flocks of investors, industry and companies raising funding rounds to San Francisco every January. A lot of companies are planning to announce the closing of their funding rounds during the conference week so I’m sure we will hear some news that creates some ‘oohs and ahhs’. .
PQA
JUNE 30, 2023
We also highlight our members' perspectives on health equity, the future of Medicare Advantage and the CMS 2024 Final Rule.
The People's Pharmacy
APRIL 20, 2023
It is spreading quickly in the US. Now that the FDA and the CDC have approved new bivalent COVID boosters, who should get a second shot? We cannot predict whether Arcturus will become a problem in the US. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF).
Expert insights. Personalized for you.
105 
Let's personalize your content